Bariatric Surgery: Many People May Be Able to Stop Taking Insulin in the Long Term
Recent studies have revealed that bariatric surgery can have a positive, long-term impact on patients who take regular insulin and suffer from type 2 diabetes. Data of more the 250 patients were studied and represented the largest medical series with the longest follow-up date currently. The results were shared at Obesity Week 2017 by Ali Aminian, MD, associate professor of surgery at the Cleveland Clinicin Ohio.
• What do the reports say: The studies show that seven years after their bariatric surgery, around 44 per cent of the patients could discontinue using insulin with their glycemic numbers at the desired level. Discontinuing the use of insulin is a significant progress in a patient’s life and improves not only life quality but also saves in medical expenses. The patients who underwent Roux-en-Y gastric bypass and sleeve gastrectomy, were also seen to have improved their blood pressure and lipid profiles. Shanu N Kothari, MD, director of the minimally invasive bariatric surgery program at Gundersen Health System, Wisconsin states that this analysis is a milestone as it gives long lasting and significant results, more impactful than other medications.
• Difference with gastric bypass: Gastric bypass is also associated with weight loss, lesser chances of weight gain, and better short term control of type 2 diabetes. The process of long-term control of type 2 diabetes is similar between these two procedures.
• Question of weight loss: Another section of patients with type 2 diabetes were further studied by Dr. Aminian and his team who found that these patients had used insulin before undergoing bariatric surgery and the results were significant. The results not only showed glycemic levels in control, but also fasting blood glucose much lesser and both without any insulin or other medicinal use. Late weight gain was also one of the observations made.
• What do the reports say: The studies show that seven years after their bariatric surgery, around 44 per cent of the patients could discontinue using insulin with their glycemic numbers at the desired level. Discontinuing the use of insulin is a significant progress in a patient’s life and improves not only life quality but also saves in medical expenses. The patients who underwent Roux-en-Y gastric bypass and sleeve gastrectomy, were also seen to have improved their blood pressure and lipid profiles. Shanu N Kothari, MD, director of the minimally invasive bariatric surgery program at Gundersen Health System, Wisconsin states that this analysis is a milestone as it gives long lasting and significant results, more impactful than other medications.
• Difference with gastric bypass: Gastric bypass is also associated with weight loss, lesser chances of weight gain, and better short term control of type 2 diabetes. The process of long-term control of type 2 diabetes is similar between these two procedures.
• Question of weight loss: Another section of patients with type 2 diabetes were further studied by Dr. Aminian and his team who found that these patients had used insulin before undergoing bariatric surgery and the results were significant. The results not only showed glycemic levels in control, but also fasting blood glucose much lesser and both without any insulin or other medicinal use. Late weight gain was also one of the observations made.
Comments
Post a Comment